Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?

Siu Hin Wan; Ambarish Pandey

doi:10.1002/ejhf.2171

Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	824-825
Number of pages	2
Journal	European Journal of Heart Failure
Volume	23
Issue number	5
DOIs	https://doi.org/10.1002/ejhf.2171
State	Published - May 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ejhf.2171

Cite this

@article{57769225de32461b83d29135acdc2259,

title = "Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?",

author = "Wan, {Siu Hin} and Ambarish Pandey",

note = "Funding Information: A.P. reports research funding from Texas Health Resources Clinical Scholarship, Gilead Sciences Research Scholar Program, the National Institute of Aging GEMSSTAR Grant (1R03AG067960‐01), and an investigator‐initiated grant from Applied Therapeutics. A.P. reports having served on the advisory board of Roche Diagnostics. Conflict of interest:",

year = "2021",

month = may,

doi = "10.1002/ejhf.2171",

language = "English (US)",

volume = "23",

pages = "824--825",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction

T2 - too soon to say no to nitric oxide?

AU - Wan, Siu Hin

AU - Pandey, Ambarish

N1 - Funding Information: A.P. reports research funding from Texas Health Resources Clinical Scholarship, Gilead Sciences Research Scholar Program, the National Institute of Aging GEMSSTAR Grant (1R03AG067960‐01), and an investigator‐initiated grant from Applied Therapeutics. A.P. reports having served on the advisory board of Roche Diagnostics. Conflict of interest:

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85104127687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104127687&partnerID=8YFLogxK

U2 - 10.1002/ejhf.2171

DO - 10.1002/ejhf.2171

M3 - Editorial

C2 - 33779018

AN - SCOPUS:85104127687

SN - 1388-9842

VL - 23

SP - 824

EP - 825

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 5

ER -

Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this